Smith Collection/Gado
Struggling genetic testing company 23andMe has been quietly exploring a possible sale of its telehealth offering, Business Insider has learned.
Smith Collection/Gado
Struggling genetic testing company 23andMe has been quietly exploring a possible sale of its telehealth offering, Business Insider has learned.
No comments